Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Cisco who wrote (1833)	11/27/1998 9:52:00 PM
From: Sigmund	Respond to of 1894

<<< Any ideas on where the price is headed? Interesting week. <<<< Of course that is the question of the day. I have no way of knowing. But for sure I will not sell under $3. Then I have to reevaluate. I think that Sakura breaks even at $4.50 so I wouldn't think the company would be sold for less than that if that is what is in the cards. I always thought that they should keep the micro division but if they sold it, it suggested the possibility that the company would be sold later as it would become a pure cyto play. Of course that changed with the additional investment in Savant. It is good to hear from you again. Hope you are well and happy and hope it was a wonderful Thanksgiving Holiday for you and your family. They can read ThinPrep so they might do a joint venture or be sold to CYTC or NPTH.